Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.4581 per EA under NDC 60687069921. Its NADAC has been published 155 times since Jul 12, 2023.
Strength
300 mg/1
Manufacturer
American Health PackagingNDC
60687069921
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA210220On Market Since
6/26/2023
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 155 times since Jul 12, 2023, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4581 per EA |
|---|---|
| All-time high | $0.5078 (Jan 10, 2024) |
| All-time low | $0.3507 (Nov 20, 2024) |
| 52-week high | $0.4752 |
| 52-week low | $0.4551 |
| Median price | $0.4704 |
| Average price | $0.4643 |
| Largest weekly change | -25.5% (Nov 20, 2024) |
| Weeks tracked | 155 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by American Health Packaging, is $0.4581 per EA (NDC 60687069921), effective Jun 24, 2026.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 7.5%. It has been tracked across 155 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Jul 12, 2023, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.3507 (Nov 20, 2024) to a high of $0.5078 (Jan 10, 2024), with a median of $0.4704 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as CEFDINIR 300 MG CAPSULE, but none are currently priced below it.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 60687069921) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification